These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 2570704

  • 1. Effect of MK-801 on the decrease in tryptophan hydroxylase induced by methamphetamine and its methylenedioxy analog.
    Johnson M, Hanson GR, Gibb JW.
    Eur J Pharmacol; 1989 Jun 20; 165(2-3):315-8. PubMed ID: 2570704
    [Abstract] [Full Text] [Related]

  • 2. MK-801 attenuates the methamphetamine induced decreased in tryptophan hydroxylase activity.
    Gibb JW, Johnson M, Hanson GR.
    NIDA Res Monogr; 1989 Jun 20; 95():511. PubMed ID: 2577049
    [No Abstract] [Full Text] [Related]

  • 3. Effect of flunarizine and nimodipine on the decrease in tryptophan hydroxylase activity induced by methamphetamine and 3,4-methylenedioxymethamphetamine.
    Johnson M, Mitros K, Stone DM, Zobrist R, Hanson GR, Gibb JW.
    J Pharmacol Exp Ther; 1992 May 20; 261(2):586-91. PubMed ID: 1374469
    [Abstract] [Full Text] [Related]

  • 4. The effects of amphetamine-like designer drugs on monoaminergic systems in rat brain.
    Gibb JW, Stone DM, Stahl DC, Hanson GR.
    NIDA Res Monogr; 1987 May 20; 76():316-21. PubMed ID: 2449619
    [Abstract] [Full Text] [Related]

  • 5. In vitro reactivation of rat cortical tryptophan hydroxylase following in vivo inactivation by methylenedioxymethamphetamine.
    Stone DM, Hanson GR, Gibb JW.
    J Neurochem; 1989 Aug 20; 53(2):572-81. PubMed ID: 2568404
    [Abstract] [Full Text] [Related]

  • 6. Direct central effects of acute methylenedioxymethamphetamine on serotonergic neurons.
    Schmidt CJ, Taylor VL.
    Eur J Pharmacol; 1988 Oct 26; 156(1):121-31. PubMed ID: 2463176
    [Abstract] [Full Text] [Related]

  • 7. Reversal of the acute effects of 3,4-methylenedioxymethamphetamine by 5-HT uptake inhibitors.
    Schmidt CJ, Taylor VL.
    Eur J Pharmacol; 1990 May 31; 181(1-2):133-6. PubMed ID: 1974853
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The N-methyl-D-aspartate antagonist MK-801 protects against serotonin depletions induced by methamphetamine, 3,4-methylenedioxymethamphetamine and p-chloroamphetamine.
    Farfel GM, Vosmer GL, Seiden LS.
    Brain Res; 1992 Nov 06; 595(1):121-7. PubMed ID: 1361410
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain.
    Stone DM, Stahl DC, Hanson GR, Gibb JW.
    Eur J Pharmacol; 1986 Aug 22; 128(1-2):41-8. PubMed ID: 2875893
    [Abstract] [Full Text] [Related]

  • 13. Glucocorticoids and 3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity.
    Johnson M, Stone DM, Bush LG, Hanson GR, Gibb JW.
    Eur J Pharmacol; 1989 Feb 28; 161(2-3):181-8. PubMed ID: 2470597
    [Abstract] [Full Text] [Related]

  • 14. Effects of 3,4-dihydroxymethamphetamine and 2,4,5-trihydroxymethamphetamine, two metabolites of 3,4-methylenedioxymethamphetamine, on central serotonergic and dopaminergic systems.
    Johnson M, Elayan I, Hanson GR, Foltz RL, Gibb JW, Lim HK.
    J Pharmacol Exp Ther; 1992 May 28; 261(2):447-53. PubMed ID: 1349640
    [Abstract] [Full Text] [Related]

  • 15. Effects of N-ethyl-3,4-methylenedioxyamphetamine (MDE) on central serotonergic and dopaminergic systems of the rat.
    Johnson M, Hanson GR, Gibb JW.
    Biochem Pharmacol; 1987 Dec 01; 36(23):4085-93. PubMed ID: 2446629
    [Abstract] [Full Text] [Related]

  • 16. Effects of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine isomers on central serotonergic, dopaminergic and nigral neurotensin systems of the rat.
    Johnson M, Letter AA, Merchant K, Hanson GR, Gibb JW.
    J Pharmacol Exp Ther; 1988 Mar 01; 244(3):977-82. PubMed ID: 2472482
    [Abstract] [Full Text] [Related]

  • 17. A comparison of the neurotoxic potential of methylenedioxyamphetamine (MDA) and its N-methylated and N-ethylated derivatives.
    Stone DM, Johnson M, Hanson GR, Gibb JW.
    Eur J Pharmacol; 1987 Feb 10; 134(2):245-8. PubMed ID: 2883012
    [Abstract] [Full Text] [Related]

  • 18. Differences in the central serotonergic effects of methylenedioxymethamphetamine (MDMA) in mice and rats.
    Stone DM, Hanson GR, Gibb JW.
    Neuropharmacology; 1987 Nov 10; 26(11):1657-61. PubMed ID: 2448703
    [Abstract] [Full Text] [Related]

  • 19. The N-methyl-D-aspartate (NMDA) receptor antagonist, dextrorphan, prevents the neurotoxic effects of 3,4-methylenedioxymethamphetamine (MDMA) in rats.
    Finnegan KT, Skratt JJ, Irwin I, Langston JW.
    Neurosci Lett; 1989 Nov 06; 105(3):300-6. PubMed ID: 2574428
    [Abstract] [Full Text] [Related]

  • 20. Depression of rat brain tryptophan hydroxylase activity following the acute administration of methylenedioxymethamphetamine.
    Schmidt CJ, Taylor VL.
    Biochem Pharmacol; 1987 Dec 01; 36(23):4095-102. PubMed ID: 2891359
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.